The Mycobacterial cell wall contains a peptidoglycan-glycolipid complex and various more or less defined glycolipid fractions. The detailed chemical structure of the peptidoglycan and the glycolipid (a mycolate of an arabinogalactan) is discussed. Figure 4 shows a tentative formula for a 'monomer' of the cell wall and Figure 6 depicts a possible 'decamer.' Then the chemistry ofthree glycolipids which seem closely associated with the cell wall is reviewed: (1) Wax D of human strains is a mucopeptide-containing mycolate of arabinogalactan and is probably derived from the cell wall by enzymatic degradation as shown in Figure 6 ; (2) Cord factor is a dimycolate of trehalose (formula 22); (3) A newly defined sulpholipid is a 2-sulphate of a tetra-acyl trehalose (formula 26).
In this lecture, I shall try to summarize our present knowledge of the chemistry of a very complex and most fascinating natural macromolecule: the cell wall of Mycobacteria and related organisms.
'V ery complex' because we shall see that it contains lipids, peptides and carbohydrates.
'Fascinating' because there is a great deal of novel structural chemistry involved and new biosynthetic pathways to explore, and because many of the pathogenic effects of tuberde bacilli and related organisms are due to constituents of the cell wall.
Weshall be concerned not only with theinsoluble macromolecular, rigid cell walland its covalent chemical structure, but also with a series of soluble Iipid compounds which seem to be located in or on the outer part of the cell wall, such as wax D, cord factor and sulpholipids.
We shall start with a chemical study of the various structures, and shall see that mass spectrometry has been a most helpful tool for bringing precision and order into this most complex field, and we shall end this lecture with a rapid survey of the biological properties of mycobacterial cell walls.
Animal experiments show indeed that preparations derived from mycobacterial cell walls have interesting properties concerning adjuvant activity, and the Stimulation of non-specific resistance, which can be used not only against bacterial and viral infections, but also against certain types of leukaemia and cancer.
I. CHEMICAL STRUCTURE OF THE MYCOBACTERIAL CELL WALL: A PEPTIDOGLYCAN GLYCOLIPID COMPLEX
The two major components of the mycobacterial cell wall are: a peptidoglycan and a glycolipid (Kotani 
(1) The peptidoglycan (mucopeptide or murein)t Here we can distinguish the glycan backhone consisting of a repeating disaccharide unit and a peptide moiety. The disaccharide unit of the mycobacterial cell wall had not yet been studied in detail; when Drs J. F. Petit and A. Adam at Orsay first isolated it from M. smegmatis by the usual enzymatic procedure 6 it was found to have Rfvalues differing from those of the classical disaccharide (1) . It did contain N-acetyl-glucosamine and muramic acid, so it was concluded that the difference was most probably in a substituent of the muramic acid moiety 13 • Mass spectrometry of the permethylated disaccharide of M. smegmatis in comparison with the permethylated derivative of 1 solved the problem 14 • The mass spectra of the two permethylated disaccharides (2) are very similar ( Figure 1 ) and show some peaks at identical positions. Others are at 30 mass units higher, in the case of the M. smegmatis disaccharide.
The fragmentation (ä) of the glycosidic linkage of 2 gives, in both cases, an oxonium ion 3 at m/e 260 confirming the terminal position of N-acetyl t The terms peptidoglycan, mucopeptide and murein are synonyms. 136 glucosamine in both disaccharides. Fragmentation (b) gives an intense peak at M -103 in both cases, confirming the presence of the lactyl side chain. Fragmentation (c) gives peaks at mje 332 or at 362. An important cleavage (d) leads to fragments 4 containing carbons C-2 and C-3 of the muramic acid moiety with their substituents; mje 201 originates from the known structure (1) whereas m/e 231 shows that in the disaccharide from M. smegmatis carbon 2 has 30 As mass spectrometry after perdeuteriomethylation proved that no methoxyl group was present in the original disaccharide, it was concluded that C-2 of muramic acid has a N -glycolyl group instead of an N -acetyl group.
N-CH
Glycolic acid was then identified chemically and N -glycolyl muramic acid 5 was synthesized 15 and found to be identical by Rfvalues and mass spectrometry after permethylation with a sample isolated from M. smegmatis disaccharide by enzymatic hydrolysis with Helix pomatia gut juice 14 We had suggested 14 that the biosynthesis of N-glycolyl muramic acid (5) proceeds by the following pathway: UDP-N-acetylglucosamine-+ UDP-N -acetylmuramic acidt-+ UDP-N-glycolylmuramic acid.
Petit et al.
1 '1 have recently obtained experimental evidence in favour of this hypothesis by isolating UDP-N-glycolyl-muramyl (Ala, Glu, DAP) from a culture of M. phlei grown in the presence of cycloserine, an antibiotic known to inhibit cell wall biosynthesis and leading to the accumulation of UDP-Nacylmuramyl derivatives in the cells of sensitive bacteria 20 • A similar experiment has been reported quite recently by Takayama et al. 21 • Mycobacteria have thus 'invented' an oxygenase which introduces a hydroxyl specifically into the N-acetyl group of muramic acid. A close analogy e:xists in higher animals: Schoop et al. 22 have shown that in pig Ii ver N-acetyl-neuraminic acid is oxidized to N-glycolyl-neuraminic acid.
(b) The peptide moiety
It was known, mainly from the papers of Work 23 and Cummins 24 • 25 , that the cell wall of Mycobacteria and Corynebacteria contains o-and L-alanine, D-glutamic acid and meso-2,6-diaminopimelic acid (DAP).
More recently, Kato et al. 26 elaborated structure 6 for the mucopeptide of the cell wall of C. diphtheriae, which is the sameasthat of the cell wall of E. coli and B. megaterium, i.e. L-Ala-y-n-Glu-L-meso-DAPt-o-Ala (Van Heijenoort et a/. 27 ) except that the carboxyl groups of Glu and DAP are amidated.
Taxonomie considerations and recent work of Migliore and Jolles 29 on wax D (see below) werein favour of an analogaus structure for the peptide moiety of mycobacterial cell walls.
The tetrapeptide of M. smegmatis cell wall was isolated by Mrs J. Wietzerbin-Falszpan and Dr J. F. Petit by enzymatic hydrolysis and extensively purified; chemical analysis confirmed that a y-glutamyl-linkage was present and that the N-terminal Ala was L, the C-terminal Ala was t Mycobacteria do contain small quantities of N-acetyl muramic acid 13 . t DAP: 2,6-diamino pimelic acid.
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D and that :OAP was meso; mass spectrometry of the N-acetylated and permethylated tetrapeptide, performed by Dr B. C. Das, then confirmed structure 7 31 , in particular the sequence of the amino acids, the presence of two amide groups and their location, as weil as the linkage of L-Ala-"(-D-Glu in ct of the carboxyl of meso-DAP carrying o-Ala.
L-Ala
In the ma-ss spectrum of 8 ( Figure 2) E~"'-o
The same diamidated tetrapeptide 7 has been isolated from BCG, M. phlei and C. fermentans and identified by mass spectrometry 31 • Similarly the structure of a diamidated tripeptide Ala-Glu-DAP was established. Mass spectrometry has been particularly useful for locating the amide groups.
We can therefore propose structure 10 for the peptidoglycan monomer of Mycobacteria: in the polymer, the C-terminal carboxyl of D-Ala is linked to one of the amino groups of meso-DAP of another glycan strand (as in 6).
As the tetrapeptide 7 was isolated by the action of the Myxobacter Al 1 enzyme which does not seem to hydrolyse D-Ala-meso-DAP bonds, it is probable that peptide 7 is found as such in the cell wall, i.e. not crosslinked to other peptide chains; it might be formed by the action of autolytic enzymes necessary for regulation of cell growth.
The only stereochemical detail not yet known in structure 7 is which of the asymmetric centres of meso-DAP is linked to Glu and n-Ala (the carboxyl of the other being amidated (ii) the nocardic ( or nocardomycolic) acids, rauging from C 40 to C 60 produced by strains of Nocardia.
(iii) the mycobacterial mycolic acids, rauging from c60 to c90· (i) The corynomycolic acids-The first to be discovered 44 and the most widely distributed in nature is corynomycolic acid C 32 H 64 0 3 11, which has also been found recently in N ocardia asteroides 45 esterified to trehalose and in M. smegmatis, esterified to glucose 45 a; the mono-unsaturated corynomycolenic acid C 32 H 62 0 3 12 46 has also been found in N. asteroides esterified to trehalose 45 . More recently 'corynomycoladienoic' acids having one unsaturation in each ofthe chains have been found by Welby-Gieusse et al. 41 in C. hofmanii, by Ioneda et al. 45 (ii) The nocardic acids-These acids were discovered by Michel et al. 49 in N. asteroides; the precise structure of some of these was later established by mass spectrometry 50 . More recently, nocardic acids (also called nocardomycolic acids 42 ) ranging from C 40 to C 60 have been isolated from various strains of Nocardia ~ saturated. mono-, di-and tri-unsaturated species have been identified 51 . In all of these the cx-chain is saturated. Bordet and MicheP 
Cs2H9s03 Cs4Hlo203 Cs6Hlo603 n = 13,15
Cs2H1o2Ü3 n = 13 to 16 n 1 = 6 to 9 n 2 = 4 to 10 R = CH3-(CH2)n 1 -CH=CH-(CH2)n 2 -CH= c:CH-(CH2)n 3 n 1 = 6 to 9 n 2 + n 3 = 6 to 15
t An organism apparently unrelated to Mycobacteria.
t Table 1 . Structures of some mycolic acids of M ycobacteria 61 
M ycolic acid
Cz<~-H49
CssH11,sÜ4 (iii) Mycolic acids of Mycobacteria-We shall not describe in detail the chemistry of these compounds which range from C 60 to C 90 ; some typical structures are shown in Table 1 and in formulae 16, 17 and 25 (for reviews see refs 39, 42) .
It is satisfying to leam from a recent paper of C. Asselineau et al. 54 that the stereochemistry of six mycolic acids examined, including a corynomycolic acid, a nocardomycolic acid and four from M ycobacteria, is the same: 2R,3R.
The biosynthesis of mycolic acids has been studied by Gastambide 5 5 and Etemadi 56 • 57 in our laboratory; it proceeds by condensation of one long chain molecule in tt of another one.
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Quite recently Winder et a/. 58 have reported that isoniazid inhibits mycolic acid biosynthesis.
The methyl branches or methylene groups of the cyclopropane rings of the long mycolic acid chains are introduced by C-methylation, methionine being the donor of the C 1 unit
Tuberculostearic acid (10-methyl stearic acid), the methyl substituent of which arises by C-methylation of oleic acid, is widely distributed amongst Mycobacteria, Nocardia and Streptomyces 60 ; the C-alkylation reactions leading to branched chain mycolic acids seem, however, to be restricted to M yco bacteria.
~1ycolic acids are mostly found in Nature esterified with carbohydrates: with arabinose in the cell wall and in wax D, and with trehalose in 'cord factor' as mentioned below.
(Fora review on mycobacterial glycolipids see ref. 61 ).
(b) The arabinogläctan The arabinogalaCtan has been studied by Misaki and Yukawa 62 , Azuma et al. 6 3 and Vilkas et al. 64 • 6 5 ; it possesses a branched structure and consists mainly of 1 ~ 5 linked D-arabinofuranose units and 1 ~ 4 linked Dgalactopyranose units, the two sugars being in approximate molecular proportians of 5 to 2; some of the arabinose units form non-reducing terminal ends. 
).
The structure of the mycolates of arabinofuranose has been studied by Acharya et al. 67 by mass spectrometry of the peracetylated compounds isolated from the cell walls of the BCG strain and of M. kansasii (Figure 3) .
In the higher mass region one finds two series of peaks differing by 100 mass units due to the presence of acyl residues corresponding to the mycolic acids (16) and (17) the structure of which had been established previously by mass spectrometry of the methyl esters. The peaks corresponding to the acyl of (16) are at mje 1444, 1416 and 1388 and arise apparently by the loss of two molecules of acetic acid (120 m.u.) from the peracetylated compound shown in Figure 3 . The ions corresponding to the acyl of (17) are at m/e 1344, 1316 and 1288. The anhydro-acyl ions (R-C=C-C=O) corresponding to (16) give I I H C24H49 (after loss of one H) peaks at m/e 1228, 1200 and 1172; the analogous ions derived from the acyl of (17) are at m/e 1128, 1100 and 1072.
A small peak at mje 217 (not shown in Figure 3) can be due to the oxonium ion (18 It seems safe to conclude that in mycobacterial cell walls, as weil as in wax D (see below), the lipid moiety consists exclusively of mycolic acids and that they are esterified to the 5-0H of D-arabinofuranose.
The cell wall of Nocardia strains has a quite analogous structure where the mycobacterial inycolic acids are replaced by nocardic acids; Laneelle and Asselineau 69 
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In one strain of N ocardia asteroides it was found by Ioneda et al. 45 that only the cell wall contained nocardic acids (C 50 to C 58 ), whereas the free Iipids contained corynomycolic acids (C 28 to C 36 ).
148 . This suggests that there might be a phosphodiester linkage of the glycan backhone to the arabinogalactan but there is as yet no clear experimental proof. Considering the probability of a phosphodiester bridge we can propose for the glycolipid peptidoglycan 'complex' of the mycobacterial cell wall the structure shown in Figure 4 ; Kanetsuna 71 has obtained some evidence for another, glycosidic, linkage existing between the glycolipid and possibly glucosamine of the mucopeptide, and has proposed the structure shown in Figure 5 .
The molecular weight of a 'monomer' such as that shown in Figure 4 is about 3 200: Misaki et al. 3 have found that the molecular weight of the arabinogalactan of the BCG strain is approximately 30000. Considering that only about one out of eight to ten molecules of muramic acid is phosphorylated one can propose the (very hypothetical) scheme of a 'decamer' shown in Figure 6 li. GLYCOLIPIDS ASSOCIATED \\ITH THE CELL WALL Under this heading we shall consider the following categories of compounds: wax D, cord factor and sulpholipids.
(1) Wax D Wax D is the acetone insoluble fraction of a chloroform extract of Mycobacteria previously defatted by exhaustive treatment with alcohol--ether42.
Many attempts have been made to purify wax D, but no homogeneaus preparation has so far been obtained. Phospholipids and cord factor are frequent contaminants. The presence of mannose reported previously in various wax D preparations was due to contamination by phospholipids (Vilkas et al. 7 5 Bound wax D Anderson 37 bad already found that part of the lipids of Mycobacteria can only be extracted after hydrolysis of the insoluble bacterial residue with 0.1 N HCl; these 'bound lipids' are chemically very similar to wax D preparations of 'non-human' strains (i.e. they are nitrogen-free mycolates of arabinogalactan).
Kotani et al. 76 and Kanetsuna 71 have isolated a 'bound wax D' from the cell wall of Mycobacteria by treatment with Iysozyme and Streptomyces enzymes. These preparations contain a mycolate of arabinogalactan linked to the mucopeptide and are thus closely similar to the mucopeptide containing wax D preparations extractable by chloroform from human strains of M. tul1'6rculosis and from M. kansasii.
The so-called 'bound Iipids', liberated by weak acid hydrolysis, are thus apparently none other than the arabinogalactan-mycolates of the cell wall, whereas the 'bound wax D' liberated by enzymatic hydrolysis can be considered to be a sort of 'monomer' of the cell wall.
The biogenesis of wax D
The chloroform-soluble wax D fractions are probably either oligomers or parts of oligomers of the cell wallnot having been used for polymerization, or autolysis products, liberated from the cell wall by the action of autolytic enzymes hydrolysing the polymer at various linkages and thus producing a complex mixture of analogues 71 • The arrows in Figure 6 show how such wax D fractions could be formed; the action of a phosphodiesterase (E) would yield a liposoluble arabinogalactan-mycolate (wax D of 'non-human' strains) whereas the action of Iysozyme (L) and a o-alanine-endopeptidase (A) would yield mucopeptide containing wax D fractions such as are found in human strains and in M. kansasii.
David et al. 71 have quite recently reported that the synthesis of wax D in M. tuberculosis is inhibited by cycloserine; this finding is in favour of a common biosynthetic pathway for cell walls and wax D and in agreement with the sequence:
UDP-precursor ~ cell wall-+ wax D.
Wax D of N ocardia strains
Quite recently Laneelle and Asselineau 69 have isolated from N. brasiliensis a wax D fraction, hydrolysis of which gives nocardic acids, galactose and arabinose as well as Ala, Glu and DAP.
(2) Cord factor
Cord factor is a toxic glycolipid discovered by Bloch 78 in petrot ether extracts ofvirulent, cord-forming Mycobacteria. (For reviews on the structure, synthesis and biological activity, see refs. 79, 80.)
Noll et al. 81 have shown that cord factor is a 6,6'-dimycolate of trehalose and, at a time when precise structures for mycolic acids were not yet known, formula (22) was proposed.
Since then a whole series of natural diesters of trehalose have been isolated from bacteriallipids; let us mention them by increasing molecular weight of the acyl radical they contain.
In M. fortuitum Vilkas et al. 82 • 83 have found a dipalmitate of trehalose and a diester of trehalose; the mass spectrum of the latter showed unambiguously that the trehalose molecule was unsymmetrically substituted, both acyl radicals (mostly palmitic and tuberculostearic acids) being on the same glucose moiety.
From Corynebacterium diphtheriae Ioneda et al. 84 have isolated a toxic glycolipid containing trehalose and two molecules of C 32 acids. coryno-mycolic (11) and corynomycolenic (12) acid. Here again trehalose is esterified in the 6,6' -position, as shown by permethylation studies.
C. hofmanii contains a trehalose diester of the C 36 corynomycoladienoic acid (13) 47 .
Quite recently we became interested in the structure of cord factor of N ocardia strains, which had not yet been examined. We had expected to find diesters of nocardic acids and in.fact from N. rhodochraus a trehalose diester was isolated containing nocardic acids ranging from C 40 to C 46 , but in a strain of N. asteroides the acyl groups of the isolated cord factor were a mixture of corynomycolic acids, corynomycolenic and corynomycoladienoic acids ranging from C 28 to C 36 45 . Thus this glycolipid was structurally closely related to the one produced by Corynebacteria. We then wondered whether this particular strain did produce nocardic acids; a detailed mass spectrometric analysis showed that in the free Iipids only corynomycolic acids were found, whereas saponification of the cell wall gave nocardic acids ranging from C 50 to C 56 . This shows that nocardic acids are specifically used for the glycolipid of the cell wall 45 (in agreement with Observations of Bordet et al. 85 ).
M ass spectrometry of trehalose diesters
Adam et al. 86 have studied the mass spectrometry of some synthetic 6,6'-diacyl-trehaloses prepared for biological experiments 87 ; it was intended to check the structure of these and analogaus natural compounds and to see how far mass spectrometry could be used in the high molecular weight region.
The peracetylated synthetic 6,6'-dieicosanoyl-trehalose 23 gave a molecular ion at mje 1238; the cleavage of the glycosidic bond Ieads to an oxonium ion at mje 611.
Mass spectrometry of the peracetylated cord factor of C. diphtheriae showed that three different molecular species were present; a trehalose diester having two saturated C 32 acyl radicals, another having two unsaturated C 32 acyl radicals and a third species having one saturated and one unsaturated acyl radical (molecular ions at m/e 1630, 1632 and 1634 88 ) . Before analysing the cord factor of a human strain of M. tuberculosis Adam et al. 86 prepared the methyl ester of the mycolic acids it contained and analysed them by mass spectrometry. A series of homologaus mycolic acids was found, ranging from C 78 H 1 54 0 4 to C 90 H 178 0 4 and containing one methyl, one methoxyl group and one cyclopropane ring on the long chain, a structure which seems typical for mycolic acids of human strains of M. tuberculosis (see Table 1 ).
The peracetylated cord factor gave a mass spectrum (Figure 8 ) showing no molecular ions (which would have been at m/e 2 776 to m/e 3 000) but a 154 series of homologous peaks at mje 1388, 1416, 1444, 1472 and 1500, corresponding to oxonium ions 25 (after loss of one Ht). The peaks at m/ e 1 072 to 1240 are due to the corresponding acyl ions of the homologous series of mycolic acids (fragmentation a), after loss of one molecule of acetic acid; the peak at m/e 325 corresponds to C 22 H450 (fragmentation b); the identification of peaks at mje 1530, 1242, 417 and 418 is described in the original paper 86 .
Some comments on the biological properties of cord factor
In the first few years after the discovery of cord factor, its toxic properties were mainly studied; experiments attempting to produce immunity with cord factor or 'anticord factors' had failed; more recently, however, Bekierkunst et al. 89 have shown that, under certain experimental conditions (in the presence of mineral oil), injections of 10 to 20 J..lg of cord factor into mice produce granulomas in the lung and local immunity.
Kato 90 has studied the action in vivo and in vitro of cord factor on mitochondria and has found that it causes the structural disintegration of the mitochondrial membrane and a decrease in mitochondrial respiration and phosphorylation.
BCG (and other mycobacteria) increase the susceptibility of experimental animals to endotoxins of' gram-negative bacteria; from the experiments of Suter 91 it seems that cord factor alone has this (rather undesirable) property; bacteria, previously defatted with acetone, have lost this property (when injected in saline; unpublished experiments with L. Chedid and A. Lamensans).
Trehalose diesters have been found more recently also in micro-organisms not related to Mycobacteria, thus Okazaki et a/. 48 have found a trehalose diester ofthe C 36 -corynomycoladienoic acid 13 in Brevibacterium thiovaginalis and trehalose diesters of partially undefined structure have been found recently by Suzuki et al. 92 in bacteria grown exclusively on paraffm as carbon source (Arthrobacter paraffineus and others). These authors write: 'the trehalose Iipids displayed a significant activity as a surface active agent when added to mixtures of n-paraffm and aqueous solution. This suggests that this Iipid may play a possible role in n-paraffin utilization by this micro-organism'. They also mention the analogy with hydrocarbon-utilizing yeasts (Torulopsis) in which the occurrence of sophorose Iipids has been reported; the latter participate in dispersion of n-paraffm and the aqueous solution of nutrients.
It thus seems that the detergent properties of trehalose diesters are used by bacteria for absorption of Iipids. Preliminary data suggested that the cytochemical neutral-red fixing activity of viable, cord-forming virulent tuberde bacilli was attributable to the sulpholipid; subsequently Gangadharam et al. 94 found a correlation between Ievels of sulpholipid elaborated by twelve different strains and their order of infectivity for the guinea-pig, thus suggesting a possible role ofthis Iipid in the pathogenesis of tuberculosis.
Quite recently, Goren 95 has described the isolation of a mixture of sulpholipids of the virulent human strain H 37 Rv and has unravelled the principal features of the structure of one of these (26) .
Trehalose is esterified by four acyl radicals and one molecule of sulphuric acid, the latter being on the 2-0H of one glucose moiety which carries one fatty acyl group on the 6-0H. The other glucose moiety carries three acyl groups, on the 2, 3 and 6 positions.
Goren 95 had shown that at least three of the four acyl radicals of the sulpholipid are different (acids A, B and C); acid B had been identified with palmitic acid.
A closer examination of the structure of the acyl radicals by mass spectrometry 96 homologaus acids representing a new type of hydroxy acids (27) showing a repeating sequence of methyl groups. Mass spectrometry shows the presence of acids having 31, 34, 37 and 40 carbon atoms. After elimination of the hydroxyl group of acid C a compound was obtained the methyl ester of which was identical with the one derived from acid A which thus has structure 28, resembling closely the structure of the mycocerosic acids (for instance) (29) ; the latter, however, are laevorotatory w hereas acids A and C are dextrorotatory and have thus the same stereochemistry as the dextrorotatory phtienoic acids (for instance) (30) .
The biosynthesis of acids A and C by condensation of palmitoyl CoA with five to eight successive propionate units is most likely, in view of the presence of the homologaus series of c3b c34• c37 and c40 acids and in view of previous studies of Gastambide 101 have observed distinct differences of the surface structure of colonies of mycoside-containing and mycoside-free strains; it thus seems that mycosides arealso located on the surface of the cells.
We have reviewed their chemistry in recent years 61 • 102 ; no significant advance seems to have been made since.
A glucan has been described by several authors aild is possibly located on or in the cell wall 62 • 65 .
The lipopeptide: several 'non-mucopeptide' amino acids have been identified in hydrolysates of cell walls. These can be isolated in a separate fraction after acetolysis or action of Myxobacter ALl enzyme and seem tobe part of a lipopeptide ( or peptidolipid) which is possibly linked to the cell wall in a way analogaus to that described by Braun and Sieglin 103 for a murein-lipoprotein of E. coli cell wall (Petit et al., Vilkas et al., unpublished) .
It is difficult, for the moment, to reconcile the probably rather simplified picture we have given of the mycobacterial cell wall with the results of an electron microscope investigation by Imaeda et af.1°4 who distinguish 'an outermost layer composed of lipopolysaccharides containing glucose, galactose and arabinose, a middle layer being a lipopolysaccharide-lipidprotein-complex and an innermost layer containing the lipopolysaccharidemucopeptide complex which consists of fibril-containing mycolic acidpolysaccharide embedded in a membraneaus arabinogalactan-mucopeptide layer'. See also Winderand Rooney 105 •
IV. BIOLOGICAL ACTIVITIES OF MYCOBACTERIAL CELL WALLS
The study of the chemistry of bacterial cell walls is actively pursued in many laboratories and is amply justified by its intrinsic importance. Mycobacterial cell walls have, however, an additional interest: they produce in experimental animals a series of biological events which Iead to increased production of antiborlies and, in general, an increase of the resistance to infections not only by Mycobacteria, but also by agents quite unrelated to M yco bacteria.
These ·biological effects are an additional stimulus for our studies and open interesting possibilities for clinical applications; they are summarized below.
(1) Specific immunization against tuberculosis
Anacker et a/. 106 have described, in a series of papers, the immunization against tuberculous infection of experimental animals with oil-treated mycobacterial cell walls. More recently, however, they have shown 107 that their cell wall preparations can be inactivated by organic solvent extraction and by alkali or Iipase treatment; these inactivated preparations combined with a wax D fraction were again highly protective.
It is not known how specific is the immunization described by Anacker et al.1o6, 1o7.
(2) Adjuvant activity
Freund's adjuvant 108 (mycobacterial cells in a water in oil emulsion containing the antigen in the water phase) is well known to immunologists109· 110 . The mucopeptide containing wax D fractions of human strains and of M. kansasii can replace the whole mycobacteria in Freund 's adjuvant 11 1. 112 . This observation allowed the study of the specificity of adjuvant action; it could thus be concluded that the mucopeptide as well as the long chain mycolic acids are necessary. Structures such as those shown in Figure 4 or Figure 5 seem to be the minimal requirement for adjuvant activity.
Fora recent review on the mechanism of adjuvant action see Paraf 113 .
(3) Stimulation of non-specific resistance to infections
Antibacterial action
Dubos et al. 114 • 115 have shown that injection of intact mycobacterial cells into mice can produce immunity to heterologous infections.
Howard et al. 116 have reported that, in mice, BCG produces a stimulatory effect on the phagocytic activity of the reticuloendothelial system and thus increases resistance 'to infection with Salmonella enteridis.
Weiss et al. Table 2) .
Antiviral and ant'itumour action
Gorhe et al. 120 have shown that pretreatment of mice with Freund's complete adjuvant or adjuvant-active wax D preparations shortens the delay of production of interferon appearance after an injection of virus and thus has a beneficial effect on viral infections.
Several authors have studied the favourable effects of BCG infections on viral leukaemia (Lernende et al. Halpern et al. 125 have shown that in rats BCG inhibits the growth of a transplanted tumour (atypical epithelioma T-8) and the development of 159 Clinical experiments with successful application of BCG to the treatment of acute lymphöblastic leukaemia have been reported by Mathe et a/. 129 • lt seems rather probable that some, at least, of these effects of whole BCG cells are due to the glycolipid-mucopeptide complex discussed above; 160
analogaus experiments with C. parvum containing a 'reticulostimuline' are in agreement with this hypothesist. The task of the chemist-There can be no doubt that whole mycobacterial cells and some of their fractions stimulate the reticuloendothelial system and that this property could find interesting applications in the treatment of human diseases. · Whole mycobacterial cells have, however, several disagreeable side-effects, such as sensitization to tuberculin and to endotoxins, granuloma formation, etc. We may thus ask: would it be possible to isolate mycobacterial fractions having only the desirable effects?
It is too early to give an answer to this question; a first approach consists of defining the minimal chemical structure responsible for the 'desirable effect' (adjuvant action andjor stimulation of the reticuloendothelial system).
This seems to be possible, for the moment, only for adjuvant activity, where it is known that active wax D preparations must contain the mucopeptide and mycolic acids. No data are yet available concerning the structural specificity of the arabinogalactan moiety.
We conclude that structures such as 10 or those shown in Figures 4 and 5 are necessary for full adjuvant activity. Would a monomerbe fully active, or only an oligomer, or a polymer? lt is too early to give an answer to this question.
We may then ask if it will be possible to obtain fractions having only adjuvant activity and no 'reticulostimuline' action and vice-versa. Preliminary experiments of L. Chedid and A. Lamensans with preparations obtained by A. Adam and J. F. Petit show that this seems possible.
t Prevot et al. 130 have reported that the anaerobic C. parvum has a strong ·reticulostimuline' activity; the cell walls of this strain are also active 131 ; their mucopeptide contains LL-diaminopimelic acid 132 . The task of the ehernist will be to degrade mycobacterial cell walls by gentle, mostly enzymatic methods, to try to isolate the simplest type of molecule having still one or another of the 'desirable activities'; this work must of course be pursued in close contact with competent biologists. At the sametime synthetic model compounds will have tobe prepared so as tobe able to obtain, finally, active compounds by total synthesis.
This may yet take several years of hard work, but the prospects of success seem fair and the goal rewarding.
